Refinement of genetic signals for psoriasis by combining European-origin and South Asian populations

Researchers report progress towards understanding which genes play the biggest roles in psoriasis.

5:00 AM

Author | Noah Fromson

lab notes general image of stethoscope drawn in blue ink on lined paper
Michigan Medicine

A Michigan Medicine study found that combining genetic samples from patients of different ethnic backgrounds created a clearer picture for analyzing genetic variants in psoriasis patients and led to the discovery of new genetic signals.

In this international effort, researchers analyzed blood samples from 2,590 psoriasis cases and 1,720 control subjects of South Asian origin, most seen at dermatology clinics in India and Pakistan. The group of South Asian volunteers was then compared to a much larger existing group of psoriasis cases and controls of European origin.

SEE ALSO: For psoriasis, targeting skin protein may help control inflammation

The goal was to compare the frequency of genetic variants – which exist in everyone – between the cases and the controls to help understand which genes are the most important drivers of psoriasis. They found that inclusion of South Asian subjects allowed them to identify two psoriasis genetic signals that they had not previously discovered. The results are published in Human Genetics and Genomics Advances.

SEE ALSO: For psoriasis, molecular signature in healthy-appearing skin may be best predictor of response to anti-TNF treatment

"We found that these European-origin and South Asian populations were not greatly different in genetic terms, meaning that we could combine them in genome-wide association studies," said James Elder, M.D., Ph.D., senior author of the paper and Kirk D. Wuepper Professor of Molecular Genetic Dermatology at Michigan Medicine. "This can be very valuable for mapping genetic susceptibility signals not only in psoriasis, but other conditions as well. Due to the large effects of Human Leukocyte-Associated genes on immune system function, combining these two populations allowed us to pinpoint several genetic variations within HLA genes that are very likely to play a causal role in psoriasis, by either altering the antigen-presenting function of these genes, or the way that they are regulated in cells of our immune system."

A genome-wide association study allows researchers to zero in on particular genetic regions, bringing them closer to identifying what particular genes are experiencing altered structures or regulation due to a disease. Elder says this study is another step towards connecting these genetic signals to the genes they affect in psoriasis.

"In order to be able to develop better treatments, we have to know which gene is really being affected and how it occurs," he said. "This starts with increasing the resolution of our individual genetic profiles, which we believe will get us out of the current logjam of not knowing for sure which genes the 'genetic signals' that we have tracked down actually affect. Once we know the genes, we can start devising treatment that specifically target the proteins that they produce.  Hopefully, these differences between each of us will allow us to develop personalized medical treatments, based on the genetic differences between people that we measured in the lab during our research studies, but now can readily be tested for in the clinic."

Paper cited: "Transethnic analysis of psoriasis susceptibility in South Asians and European enhances fine mapping in the MHC and genome wide," Human Genetics and Genomics Advances. DOI: 10.1016/j.xhgg.2021.100069

"This research is supported by the National Institutes of Health."


More Articles About: Lab Notes Psoriasis Genetics Race and Ethnicity Skin Conditions
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories Provider takes a pulse oximetry reading from a patient's finger
Health Lab
Inaccurate pulse oximeter readings could limit transplants, heart pumps for Black patients with heart failure
Racially biased readings of oxygen levels in the blood using pulse oximeters may further limit opportunities for Black patients with heart failure to receive potentially lifesaving treatments, such as heart pumps and transplants
illustration of man sleeping in bed with CPAP machine on
Health Lab
Free sleep clinic addresses disparities in treatment of sleep disorders
New sleep medicine service aims to combat sleep disorders and help reduce poor health outcomes for people without health insurance.
Woman in pink shirt lifts kettleball in an outdoor exercise class
Health Lab
How to make cancer prevention more equitable
Expert explains six behavioral risk factors for cancer and why current programs don’t always meet the needs of people from racially and ethnically minoritized groups and other vulnerable populations.
Medical gloved hand holding test tube sample for HIV testing.
Health Lab
Inequities in HIV testing, diagnosis and care for people with intellectual and developmental disabilities
People with disabilities are often at higher risk for exposure to HIV due to barriers in engaging healthcare and other systemic factors and are thus considered a priority for prevention and testing efforts. However, these efforts don’t always extend to people with intellectual disabilities due to the perception that people with intellectual disabilities are mostly asexual.
Illustration of a microscope
Health Lab
Turning back the clock on photoaging skin
Experts observed in a new study that injection of the most popular type of dermal filler, cross-linked hyaluronic acid, into photoaged skin could reverse the dermal changes associated with photoaging.
Illustration of hand and enzymes that affect scleroderma patients
Health Lab
Novel antibody targets CD38 enzyme to treat systemic sclerosis
New study has identified an enzyme contributing to systemic sclerosis.